Sentinel lymph node biopsy in breast cancer:The Aarhus experience
| Autor: | Peer Christiansen, Flemming Brandt Sørensen, Anders Lernevall, Flemming Melsen, Ib Hessov, Mette Cathrine Lauridsen, Jens Peter Garne |
|---|---|
| Jazyk: | dánština |
| Rok vydání: | 2000 |
| Předmět: |
Adult
medicine.medical_specialty Patent Blue V Biopsy Mammary gland Sentinel lymph node Breast Neoplasms Metastasis chemistry.chemical_compound Breast cancer medicine Humans Radiology Nuclear Medicine and imaging False Negative Reactions Neoplasm Staging Blue dye medicine.diagnostic_test business.industry Axillary Lymph Node Dissection Hematology General Medicine medicine.disease Surgery medicine.anatomical_structure Oncology chemistry Lymphatic Metastasis Axilla Lymph Node Excision Female Radiology Lymph Nodes business |
| Zdroj: | Lauridsen, M C, Garne, J P, Hessov, I, Sørensen, F B, Melsen, F, Lernevall, A & Christiansen, P 2000, ' Sentinel lymph node biopsy in breast cancer : The Aarhus experience ', Acta Oncologica, bind 39, s. 421-422 . Lauridsen, M C, Garne, J P, Hessov, I, Sorensen, F B, Melsen, F, Lernevall, A & Christiansen, P 2000, ' Sentinel lymph node biopsy in breast cancer : The aarhus experience ', Acta Oncologica, vol. 39, no. 3, pp. 421-422 . Lauridsen, M C, Garne, J P, Hessov, I, Sørensen, F B, Melsen, F, Lernevall, A & Christiansen, P 2000, ' Sentinel lymph node biopsy in breast cancer : The Aarhus experience ', Acta Oncologica, vol. 39, no. 3, pp. 421-422 . https://doi.org/10.1080/028418600750013203 |
| Popis: | Eighty patients, with newly diagnosed unifocal breast cancer and with no axillary metastases verified by ultrasonography, underwent sentinel lymph node (SLN) and subsequent axillary lymph node dissection. To identify the SLN, we used a combination of Tc-99m labelled colloid (Albures) and blue dye (Patent Blue V) injected peritumorally. Lymphoscintigraphy was not performed. The SLN was successfully identified in 78 out of 80 patients (97.5%); 43 patients (54%) were found to have metastatic disease. In 33 patients (77%) the SLN was the only node involved. No false-negative nodes were found, defined as SLNs that tested negative but with higher nodes that tested positive. If SLN biopsy is accepted as a routine procedure and when the exact indications are defined, the method described probably could be offered to the majority of breast cancer patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|